Bisphosphonate-Associated Osteonecrosis of the Jaw: A Literature Review and Clinical Practice Guidelines

References

1. 1. Hohneker JA,
   2. Bess AL

   . Important Drug Precaution for Dental Health Professionals with Patients Being Treated for Cancer[Letter]. East Hanover NJ: Novartis Corporation; 2005. May5.
2. 1. Aredia Zometa

   . [Package inserts]. East Hanover NJ: Novartis Pharmaceuticals Corporation; 2005.
3. 1. Estilo CL,
   2. Van Poznak CH,
   3. Williams T,
   4. Evtimovska L,
   5. Halpern JL,
   6. Tunick SJ,
   7. Huryn JM

   . Osteonecrosis of the maxilla and mandible in patients treated with bisphosphonates: a retrospective study. J Clin Oncol. 2004;22(14S): 750S (abstract 8088).

   OpenUrl
4. 1. Hellstein JW,
   2. Marek CL

   . Bisphosphonate osteochemonecrosis (bis-phossy jaw): Is this phossy jaw of the 21st century?. J Oral Maxillofax Surg. 2005;63: 682-682.

   OpenUrl
5. 1. Ficarra G,
   2. Beninati F,
   3. Rubino I,
   4. Vannucchi A,
   5. Longo G,
   6. Tonelli P,
   7. Pini Prato G

   . Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol. 2005;32(11): 1123-1128.

   OpenUrlCrossRefPubMedWeb of Science
6. 1. Stark W,
   2. Epker B

   . Failure of osseointegrated dental implants after bisphosphonate therapy for osteoporosis: a case report. Int J Oral Maxillofac Implants. 1995;10: 74.

   OpenUrlPubMed
7. 1. Marx RE

   . Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic (Letter). J Oral Maxillofac Surg. 61. month_if_listed;vol(issue): 1115-1117.
8. 1. Wang J,
   2. Goodger NM,
   3. Pogrel MA

   . Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg. 2003;61: 1104-1107.

   OpenUrlCrossRefPubMedWeb of Science
9. 1. Pogrel MA

   . Bisphosphonates and bone necrosis (Letter). J Oral Maxillofac Surg. 2004;62: 391-392.

   OpenUrlPubMedWeb of Science
10. 1. Migliorati CA

    . Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncology. 2003;21(22): 4253-4254.

    OpenUrlFREE Full Text
11. 1. Ruggiero SL,
    2. Mehrotra B,
    3. Rosenberg T,
    4. Engroff SL

    . Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62: 527-534.

    OpenUrlCrossRefPubMedWeb of Science
12. 1. Bagan JV,
    2. Murillo J,
    3. Jimenez Y,
    4. Poveda R,
    5. Milian MA,
    6. Sanchis JM,
    7. Silvestre FJ

    , Scully seconCdauthorgivenname. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med. 2005;34(2): 120-123.

    OpenUrlCrossRefPubMedWeb of Science
13. 1. Melo MD,
    2. Obeid G

    . Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy. J Can Dent Assoc. 205;71(2): 111-113.
14. 1. Purcell PM,
    2. Boyd IW

    . Bisphosphonates and osteonecrosis of the jaw. Med J Aust. 2005;182(8): 417-418.

    OpenUrlPubMedWeb of Science
15. 1. Carter G,
    2. Goss AN,
    3. Doecke C

    . Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust. 2005;182(8): 413-415.

    OpenUrlPubMedWeb of Science
16. 1. Marx R,
    2. Sawatari Y,
    3. Fortin M,
    4. Broumand V

    . Bisphosphonate-induced bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. journaltitle. J Oral Maxillofac Surg;63: 1567-1575.
17. 1. Lugassy G,
    2. Shaham R,
    3. Nemets A,
    4. Ben-Dor D,
    5. Nahlieli O

    . Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med. 2004;117: 440-441.

    OpenUrlCrossRefPubMedWeb of Science
18. 1. Steiner B,
    2. Lenz JH,
    3. Gundlach KK,
    4. Freund M

    . Osteonecrosis of the jaws during treatment with bisphosphonates: diagnosis and therapy. Dtsch Med Wochenschr. 2005;130(38): 2142-45.

    OpenUrlPubMed
19. 1. Odvina CV,
    2. Zerwekh JE,
    3. Rao S,
    4. Maalouf N,
    5. Gottschalk FA,
    6. Pak CYC

    . Severely suppressed bone turnover: A potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90(3): 1294-1301.

    OpenUrlCrossRefPubMedWeb of Science
20. 1. Wood J,
    2. Bonjean K,
    3. Ruetz S,
    4. Bellahcene A,
    5. Devy L,
    6. Foidart JM,
    7. Castronovo V,
    8. Green JR

    . Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther. 2002;302: 1055-1061.

    OpenUrlAbstract/FREE Full Text
21. 1. Migliorati CA,
    2. Casiglia J,
    3. Epstein J,
    4. Jacobsen PL,
    5. Siegel MA,
    6. Woo SB

    . Managing the care of patients with bisphosphonate-associated osteonecrosis. An American Academy of Oral Medicine position paper. J Am Dent Assoc. 2005;136: 1658-1668.

    OpenUrlAbstract/FREE Full Text
22. 1. Migliorati CA,
    2. Schubert MM,
    3. Peterson DE,
    4. Seneda LM

    . Bisphosphate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer. 2005;104: 83-93.

    OpenUrlCrossRefPubMedWeb of Science
23. 1. Woo SB,
    2. Handle K,
    3. Richardson PG

    . Osteonecrosis of the jaw and bisphosphonates [letter]. N Engl J Med. 2005;353: 100.

    OpenUrl
24. 1. Maerevoet M,
    2. Martin C,
    3. Duck L

    . Osteonecrosis of the jaw and bisphosphonates [letter]. N Engl J Med. 2005;353: 100-101.

    OpenUrl
25. 1. Melo MD,
    2. Obeid G

    . Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy. Strategies for prevention and early recognition. J Am Dent Assoc. 2005;136: 1675-1681.

    OpenUrlAbstract/FREE Full Text
26. 1. Markiewicz MR,
    2. Margarone JE,
    3. Campbell JH,
    4. Aguirre A

    . Bisphosphonate-associated osteonecrosis of the jaws. A review of current knowledge. J Am Dent Assoc. 2005;136: 1669-1674.

    OpenUrlAbstract/FREE Full Text
27. 1. Durie BGM,
    2. Katz M,
    3. Crowley J

    . Osteonecrosis of the jaw and bisphosphonates [letter]. N Engl J Med. 2005;353: 99-101.

    OpenUrlCrossRefPubMedWeb of Science
28. 1. Sarathy AP,
    2. Bourgeois SL,
    3. Goodell GG

    . Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports. J Endod. 2005;31(10): 759-63.

    OpenUrlCrossRefPubMedWeb of Science